Webster AC - Search Results

1

The Seville expert workshop for progress in posttransplant lymphoproliferative disorders.

Glotz D, Chapman JR, Dharnidharka VR, Hanto DW, Castro MC, Hirsch HH, Leblond V, Mehta AK, Moulin B, Pagliuca A, Pascual J, Rickinson AB, Russo FP, Trappe RU, Webster AC, Zuckermann AO, Gross TG. Glotz D, et al. Among authors: webster ac. Transplantation. 2012 Oct 27;94(8):784-93. doi: 10.1097/TP.0b013e318269e64f. Transplantation. 2012. PMID: 22992767

2

Interleukin 2 receptor antagonists for renal transplant recipients: a meta-analysis of randomized trials.

Webster AC, Playford EG, Higgins G, Chapman JR, Craig JC. Webster AC, et al. Transplantation. 2004 Jan 27;77(2):166-76. doi: 10.1097/01.TP.0000109643.32659.C4. Transplantation. 2004. PMID: 14742976

3

Cancer after renal transplantation: the next challenge.

Chapman JR, Webster AC. Chapman JR, et al. Among authors: webster ac. Am J Transplant. 2004 Jun;4(6):841-2. doi: 10.1111/j.1600-6143.2004.00486.x. Am J Transplant. 2004. PMID: 15147414 Free article. No abstract available.

4

Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data.

Webster AC, Woodroffe RC, Taylor RS, Chapman JR, Craig JC. Webster AC, et al. BMJ. 2005 Oct 8;331(7520):810. doi: 10.1136/bmj.38569.471007.AE. Epub 2005 Sep 12. BMJ. 2005. PMID: 16157605 Free PMC article. Review.

5

Monoclonal and polyclonal antibody therapy for treating acute rejection in kidney transplant recipients: a systematic review of randomized trial data.

Webster AC, Pankhurst T, Rinaldi F, Chapman JR, Craig JC. Webster AC, et al. Transplantation. 2006 Apr 15;81(7):953-65. doi: 10.1097/01.tp.0000215178.72344.9d. Transplantation. 2006. PMID: 16612264 Review.

6

Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.

Webster AC, Lee VW, Chapman JR, Craig JC. Webster AC, et al. Cochrane Database Syst Rev. 2006 Apr 19;(2):CD004290. doi: 10.1002/14651858.CD004290.pub2. Cochrane Database Syst Rev. 2006. Update in: Cochrane Database Syst Rev. 2019 Dec 16;12:CD004290. doi: 10.1002/14651858.CD004290.pub3 PMID: 16625599 Updated. Review.

7

Target of rapamycin inhibitors (sirolimus and everolimus) for primary immunosuppression of kidney transplant recipients: a systematic review and meta-analysis of randomized trials.

Webster AC, Lee VW, Chapman JR, Craig JC. Webster AC, et al. Transplantation. 2006 May 15;81(9):1234-48. doi: 10.1097/01.tp.0000219703.39149.85. Transplantation. 2006. PMID: 16699448 Review.

8

Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients.

Webster AC, Craig JC, Simpson JM, Jones MP, Chapman JR. Webster AC, et al. Am J Transplant. 2007 Sep;7(9):2140-51. doi: 10.1111/j.1600-6143.2007.01908.x. Epub 2007 Jul 19. Am J Transplant. 2007. PMID: 17640312 Free article.

9

Managing cancer risk and decision making after kidney transplantation.

Webster AC, Wong G, Craig JC, Chapman JR. Webster AC, et al. Am J Transplant. 2008 Nov;8(11):2185-91. doi: 10.1111/j.1600-6143.2008.02385.x. Epub 2008 Sep 8. Am J Transplant. 2008. PMID: 18782291 Free article. Review.

10

Reported cancer screening practices of nephrologists: results from a national survey.

Wong G, Webster AC, Chapman JR, Craig JC. Wong G, et al. Among authors: webster ac. Nephrol Dial Transplant. 2009 Jul;24(7):2136-43. doi: 10.1093/ndt/gfp009. Epub 2009 Feb 2. Nephrol Dial Transplant. 2009. PMID: 19188339

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

271 results

Search Page

Filters